What role of the emergency medicine (EM) pharmacist has been shown to decrease door-to-needle time in patients with acute ischemic stroke?

The role of the emergency medicine pharmacist in bedside participation during patient assessment and treatment has been demonstrated to effectively decrease door-to-needle time in patients experiencing acute ischemic stroke. This involvement allows pharmacists to quickly assess medication orders, ensure appropriate treatment protocols are followed, and collaborate closely with the medical team in urgent situations.

By being present at the bedside, the pharmacist can facilitate timely interventions, optimize drug therapy, and address any potential medication-related issues that may arise during the critical window for administering thrombolytic therapy. This proactive engagement is vital in ensuring that patients receive appropriate care without unnecessary delays. The collaborative approach of the EM pharmacist ensures that medication administration is swift and efficient, leading to improved outcomes for patients requiring urgent care for acute ischemic stroke.

Other roles mentioned, while important in their own right, do not directly impact the immediacy of treatment timing during an acute event in the same way that bedside participation does.